RVBA-TAKED

Takeda — structure and aliases

Structure, aliases, and identifiers for this firm's canonical entity.

Identifiers7

ISIN
JP3463000004
wba
LEI
549300ZLMVP4X0OGR454
wba
nzt_id
COM-0282
nzt
SBTi
Ticker
4502.T
fmp_isin_resolution
wba_company_id
PT_01724
wba
Wikidata QID
Q899133
wba

Known aliases4

Legal name
TakedawbaTakeda Pharmaceutical Companycarbonplan_offset_seedTakeda Pharmaceutical Company Limitedwba
Local subsidiary
Retired on behalf of Takeda Pharmaceutical Company Limited's Scope 1 Emissions for FY2022 (i.e., 4/1/2022-3/31/2023)climate_actions_beneficiary

Corporate hierarchy

No separate parent or subsidiary relationships recorded — Takeda is treated as the consolidated reporting entity for the group. Local and divisional legal entities almost certainly exist (regional operating companies, country subsidiaries, joint ventures) but they do not file their own ESG or financial disclosures independently of the parent.

Sub-entity records will surface here only when (a) a local arm files its own report, or (b) a public registry (GLEIF, Companies House, SEC) discloses the parent-child link.